Dasatinib (Sprycel®)

Senolytic agent for removing senescent cells

Dasatinib is approved as a cancer medication, but recent attention has been focused on its ability to act as a senolytic; that is an agent that can remove ‘dead’ (senscent) cells within the body by inducing a process known as autophagy. 

 

This product features in the
following categories

Anti Aging Treatments Specialist Products

This product has the
following ingredients

Dasatinib

This product is associated with the following health conditions

Antiaging Supplements Cancer Senescent cells

Product Description

There is no doubt that dasatinib represents the cutting-edge in anti-aging medicine, perhaps even experimental in some respects, but hardcore enthusiasts are aware that senolytics are presently a major focus of research.

The current program is considered to be as follows:

A dose of 2.5mg – 5mg per Kg body weight (2.2 lbs). This dose should be divided into two and taken at least a week apart and does not need to be cycled again for 8 to 12 months.

Example: if you weigh 72 Kg (158 lbs) then the total dose is;

Minimum 72 x 2.5 = 180mg

OR

Maximum 72 x 5mg = 360mg

Divide into two e.g. 180/2 = 90mg or 360/2 = 180mg so that’s the dose for week one and again in week two.

Remember that once completed, this dose does not need to be cycled again for 8 to 12 months. If you are not sure what the recommended dose should be, please take advice from your health professional.

 



ias-category-cta

Looking for another product?